NYMX
NYMX Real Time Price USDRecent trades of NYMX by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gregory Murphy House / R | Sale $50,001 - $100,000 | Jan. 22, 2021 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NYMX's directors and management
Government lobbying spending instances
-
$30,000 Jul 20, 2022 Issue: Health Issues
-
$30,000 Apr 18, 2022 Issue: Health Issues
-
$30,000 Jan 18, 2022 Issue: Health Issues
-
$30,000 Oct 23, 2021 Issue: Health Issues
-
$30,000 Jul 22, 2021 Issue: Health Issues
-
$30,000 Apr 20, 2021 Issue: Health Issues
-
$30,000 Jan 20, 2021 Issue: Health Issues
-
$30,000 Oct 20, 2020 Issue: Health Issues
-
$30,000 Jul 20, 2020 Issue: Health Issues
-
$30,000 Apr 21, 2020 Issue: Health Issues
-
$30,000 Jan 21, 2020 Issue: Health Issues
-
$30,000 Oct 18, 2019 Issue: Health Issues
-
$30,000 Jul 12, 2019 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of NYMX in WallStreetBets Daily Discussion
Recent insights relating to NYMX
Recent picks made for NYMX stock on CNBC
ETFs with the largest estimated holdings in NYMX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NYMX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.